The Journal of Experimental Medicine
StemCell Technologies
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 31 July 2006 doi:10.1084/jem.20051557
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 203, Number 8, 2033-2042
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hangartner, L.
Right arrow Articles by Hengartner, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hangartner, L.
Right arrow Articles by Hengartner, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread

Lars Hangartner1, Raphaël M. Zellweger1, Mattia Giobbi2, Jacqueline Weber1, Bruno Eschli1, Kathy D. McCoy1, Nicola Harris1, Mike Recher1, Rolf M. Zinkernagel1, and Hans Hengartner1

1 Institute of Experimental Immunology, University Hospital Zürich, 8091 Zürich, Switzerland
2 Mettler-Toledo (Schweiz) GmbH, 8606 Greifensee, Switzerland

CORRESPONDENCE Lars Hangartner: lhangart{at}scripps.edu

The biological relevance of nonneutralizing antibodies elicited early after infection with noncytopathic persistence-prone viruses is unclear. We demonstrate that cytotoxic T lymphocyte–deficient TgH(KL25) mice, which are transgenic for the heavy chain of the lymphocytic choriomeningitis virus (LCMV)–neutralizing monoclonal antibody KL25, mount a focused neutralizing antibody response following LCMV infection, and that this results in the emergence of neutralization escape virus variants. Further investigation revealed that some of the escape variants that arose early after infection could still bind to the selecting antibody. In contrast, no antibody binding could be detected for late isolates, indicating that binding, but nonneutralizing, antibodies exerted a selective pressure on the virus. Infection of naive TgH(KL25) mice with distinct escape viruses differing in their antibody-binding properties revealed that nonneutralizing antibodies accelerated clearance of antibody-binding virus variants in a partly complement-dependent manner. Virus variants that did not bind antibodies were not affected. We therefore conclude that nonneutralizing antibodies binding to the same antigenic site as neutralizing antibodies are biologically relevant by limiting early viral spread.


Abbreviations used: CVF, cobra venom factor; GP, glycoprotein; LCMV, lymphocytic choriomeningitis virus; MFI, mean fluorescence intensity; TAP, transporter associated with antigen processing.

L. Hangartner and R.M. Zellweger contributed equally to this work.

L. Hangartner's present address is Department of Immunology IMM-2, The Scripps Research Institute, La Jolla, CA 92037.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS